Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.59 USD
Change Today +0.04 / 0.88%
Volume 2.9K
MSLP On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

muscle pharm corp (MSLP) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/8/14 - $14.20
52 Week Low
03/17/15 - $2.78
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MUSCLE PHARM CORP (MSLP)

muscle pharm corp (MSLP) Related Bloomberg News

View More Bloomberg News

muscle pharm corp (MSLP) Related Businessweek News

No Related Businessweek News Found

muscle pharm corp (MSLP) Details

MusclePharm Corporation develops, manufactures, markets, and distributes branded nutritional supplements in the United States and internationally. It offers a range of powders, capsules, tablets, and gels. The company’s MusclePharm Hybrid series products include Assault, Amino1, and Combat Protein Powder; MusclePharm core products comprise BCAA 3:1:2, CLA Core, and Fish Oil that balance the essentials to meet the day-in and day-out demands of athletes; and Arnold Schwarzenegger series physique supplements consist of protein gainers, muscle builders, multivitamins, and nitric oxide boosters. It also provides FitMiss, which is designed and formulated primarily for women lifestyle to cover various needs, including weight loss, multi-vitamins, protein shakes, detox, skin care, and pre-workout energy mixes. In addition, the company offers over-the-counter drugs and preparations, cosmetics, and natural supplements, as well as intends to develop, market, and sell apparel and accessories. MusclePharm Corporation sells its products to various fitness enthusiasts, such as football, combat sports, weight training, bodybuilding, runners, basketball, soccer, cross fit, golf, tennis, and volleyball, as well as outdoor activities, and athletic and recreational enthusiasts. The company was founded in 2008 and is headquartered in Denver, Colorado.

176 Employees
Last Reported Date: 03/16/15
Founded in 2008

muscle pharm corp (MSLP) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $639.1K
President, Director and Member of Strategic I...
Total Annual Compensation: $555.2K
Co-Founder and Executive Vice President of Br...
Total Annual Compensation: $382.8K
Chief Operating Officer
Total Annual Compensation: $313.5K
Compensation as of Fiscal Year 2014.

muscle pharm corp (MSLP) Key Developments

Muscle Pharm Corp. Adopts Amended and Restated Bylaws Effective as of August 26, 2015

Muscle Pharm Corp. Board adopted an amendment to the Company's amended and restated Bylaws effective as of August 26, 2015. Article IV - Officers: Various provisions related to officer positions and reporting relationships are modified to create a position of Executive Chairman and clarify the powers and duties of the officers. The Executive Chairman shall have such powers and perform such duties as may be assigned by the Board of Directors. The Chief Executive Officer shall supervise and direct generally all the business and affairs of the Company. The President shall have such powers and perform such duties as may be assigned by the Board of Directors, the Executive Chairman, or the Chief Executive Officer. (Section 5).

Muscle Pharm Corp. Announces Executive Changes

On August 26, 2015, the Board of Directors of MusclePharm Corporation appointed its current Chairman of the Board, Mr. Ryan Drexler, as its Executive Chairman of the Board to hold office until the next annual meeting or until his successor is duly elected and qualified with all the duties as set forth for the position of the Chief Executive Officer in the Company’s Bylaws and other governance documents duly adopted or that may be adopted by the Company. Subsequent to the Meeting, the Board reaffirmed Brad Pyat as the Chief Executive Officer, Richard Estalella as the President, John Price as the Chief Financial Officer and Cory Gregory as the Executive Vice President. In addition, as a result of re-election, the composition of the committees of the Board is reaffirmed. As such, the Company’s Audit Committee is currently comprised of Mr. Bush as the Chair, Mr. Doron, and Mr. Jenkins. The Company’s Compensation Committee is currently comprised of Mr. Doron as the Chair, Mr. Thompson and Mr. Bush. The Company’s Nominating & Governance Committee is currently comprised of Mr. Jenkins as the Chair, Mr. Thompson and Mr. Doron. The Company’s Strategic Initiative Committee is currently comprised of Mr. Thompson as the Chair, Mr. Estalella, Mr. Doron and Mr. Jenkins.

MusclePharm Corporation Announces Cessation of Appointment of James Greenwell as Chief Operating Officer

MusclePharm Corporation announced that on August 25, 2015, the appointment of James Greenwell as the company's Chief Operating Officer ceased.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSLP:US $4.59 USD +0.04

MSLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natural Grocers by Vitamin Cottage Inc $24.80 USD +0.42
Twinlab Consolidated Holdings Inc $1.60 USD 0.00
USANA Health Sciences Inc $137.93 USD -0.42
Vitamin Shoppe Inc $34.60 USD -0.30
View Industry Companies

Industry Analysis


Industry Average

Valuation MSLP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MUSCLE PHARM CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at